Associations - etoposide oral

No biomarker	Peritoneal Cancer	No biomarker	Peritoneal Cancer	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Small Cell Lung Cancer	No biomarker	Small Cell Lung Cancer	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Hodgkin Lymphoma	No biomarker	Hodgkin Lymphoma	carboplatin + etoposide oral + bendamustine Sensitive: A2 - Guideline carboplatin + etoposide oral + bendamustine Sensitive : A2	carboplatin + etoposide oral + bendamustine Sensitive: A2 - Guideline carboplatin + etoposide oral + bendamustine Sensitive : A2
No biomarker	Acute Lymphocytic Leukemia	No biomarker	Acute Lymphocytic Leukemia	ifosfamide + etoposide oral + mitoxantrone Sensitive: A2 - Guideline ifosfamide + etoposide oral + mitoxantrone Sensitive : A2	ifosfamide + etoposide oral + mitoxantrone Sensitive: A2 - Guideline ifosfamide + etoposide oral + mitoxantrone Sensitive : A2
No biomarker	Acute Lymphocytic Leukemia	No biomarker	Acute Lymphocytic Leukemia	cyclophosphamide + etoposide oral + clofarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + clofarabine Sensitive : A2	cyclophosphamide + etoposide oral + clofarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + clofarabine Sensitive : A2
No biomarker	T Acute Lymphoblastic Leukemia	No biomarker	T Acute Lymphoblastic Leukemia	cyclophosphamide + etoposide oral + nelarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + nelarabine Sensitive : A2	cyclophosphamide + etoposide oral + nelarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + nelarabine Sensitive : A2
No biomarker	Childhood B Acute Lymphoblastic Leukemia	No biomarker	Childhood B Acute Lymphoblastic Leukemia	cyclophosphamide + etoposide oral + nelarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + nelarabine Sensitive : A2	cyclophosphamide + etoposide oral + nelarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + nelarabine Sensitive : A2
No biomarker	Childhood B Acute Lymphoblastic Leukemia	No biomarker	Childhood B Acute Lymphoblastic Leukemia	cyclophosphamide + etoposide oral + clofarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + clofarabine Sensitive : A2	cyclophosphamide + etoposide oral + clofarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + clofarabine Sensitive : A2
No biomarker	Merkel Cell Carcinoma	No biomarker	Merkel Cell Carcinoma	carboplatin + etoposide oral Sensitive: A2 - Guideline carboplatin + etoposide oral Sensitive : A2	carboplatin + etoposide oral Sensitive: A2 - Guideline carboplatin + etoposide oral Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	carboplatin + etoposide oral Sensitive: A2 - Guideline carboplatin + etoposide oral Sensitive : A2	carboplatin + etoposide oral Sensitive: A2 - Guideline carboplatin + etoposide oral Sensitive : A2
No biomarker	Kaposi Sarcoma	No biomarker	Kaposi Sarcoma	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Osteosarcoma	No biomarker	Osteosarcoma	ifosfamide + methotrexate + etoposide oral Sensitive: A2 - Guideline ifosfamide + methotrexate + etoposide oral Sensitive : A2	ifosfamide + methotrexate + etoposide oral Sensitive: A2 - Guideline ifosfamide + methotrexate + etoposide oral Sensitive : A2
No biomarker	Testicular Cancer	No biomarker	Testicular Cancer	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	carboplatin + etoposide oral Sensitive: A2 - Guideline carboplatin + etoposide oral Sensitive : A2	carboplatin + etoposide oral Sensitive: A2 - Guideline carboplatin + etoposide oral Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	cisplatin + etoposide oral Sensitive: A2 - Guideline cisplatin + etoposide oral Sensitive : A2	cisplatin + etoposide oral Sensitive: A2 - Guideline cisplatin + etoposide oral Sensitive : A2
No biomarker	Cervical Cancer	No biomarker	Cervical Cancer	carboplatin + etoposide oral Sensitive: A2 - Guideline carboplatin + etoposide oral Sensitive : A2	carboplatin + etoposide oral Sensitive: A2 - Guideline carboplatin + etoposide oral Sensitive : A2
No biomarker	Cervical Cancer	No biomarker	Cervical Cancer	cisplatin + etoposide oral Sensitive: A2 - Guideline cisplatin + etoposide oral Sensitive : A2	cisplatin + etoposide oral Sensitive: A2 - Guideline cisplatin + etoposide oral Sensitive : A2
No biomarker	B Acute Lymphoblastic Leukemia	No biomarker	B Acute Lymphoblastic Leukemia	cyclophosphamide + etoposide oral + clofarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + clofarabine Sensitive : A2	cyclophosphamide + etoposide oral + clofarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + clofarabine Sensitive : A2
No biomarker	B Acute Lymphoblastic Leukemia	No biomarker	B Acute Lymphoblastic Leukemia	ifosfamide + etoposide oral + mitoxantrone Sensitive: A2 - Guideline ifosfamide + etoposide oral + mitoxantrone Sensitive : A2	ifosfamide + etoposide oral + mitoxantrone Sensitive: A2 - Guideline ifosfamide + etoposide oral + mitoxantrone Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	cyclophosphamide + etoposide oral Sensitive: A2 - Guideline cyclophosphamide + etoposide oral Sensitive : A2	cyclophosphamide + etoposide oral Sensitive: A2 - Guideline cyclophosphamide + etoposide oral Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	carboplatin + cyclophosphamide + etoposide oral Sensitive: A2 - Guideline carboplatin + cyclophosphamide + etoposide oral Sensitive : A2	carboplatin + cyclophosphamide + etoposide oral Sensitive: A2 - Guideline carboplatin + cyclophosphamide + etoposide oral Sensitive : A2
No biomarker	Merkel Cell Carcinoma	No biomarker	Merkel Cell Carcinoma	cisplatin + etoposide oral Sensitive: A2 - Guideline cisplatin + etoposide oral Sensitive : A2	cisplatin + etoposide oral Sensitive: A2 - Guideline cisplatin + etoposide oral Sensitive : A2
MLL-AFF1 fusion	Acute Lymphocytic Leukemia	MLL-AFF1 fusion	Acute Lymphocytic Leukemia	etoposide oral Sensitive: B - Late Trials etoposide oral Sensitive : B	etoposide oral Sensitive: B - Late Trials etoposide oral Sensitive : B
HER-2 positive	HER2 Positive Breast Cancer	HER-2 positive	HER2 Positive Breast Cancer	etoposide oral Sensitive: C3 – Early Trials etoposide oral Sensitive : C3	etoposide oral Sensitive: C3 – Early Trials etoposide oral Sensitive : C3
Chr t(22)	Germ Cell Tumors	Chr t(22)	Germ Cell Tumors	cisplatin + ifosfamide + etoposide oral Sensitive: C4 – Case Studies cisplatin + ifosfamide + etoposide oral Sensitive : C4	cisplatin + ifosfamide + etoposide oral Sensitive: C4 – Case Studies cisplatin + ifosfamide + etoposide oral Sensitive : C4
EGFR exon 19 deletion + EGFR T790M	Small Cell Lung Cancer	EGFR exon 19 deletion + EGFR T790M	Small Cell Lung Cancer	etoposide oral Sensitive: C4 – Case Studies etoposide oral Sensitive : C4	etoposide oral Sensitive: C4 – Case Studies etoposide oral Sensitive : C4
TOP2A overexpression	Adrenal Cortex Carcinoma	TOP2A overexpression	Adrenal Cortex Carcinoma	etoposide oral Sensitive: D – Preclinical etoposide oral Sensitive : D	etoposide oral Sensitive: D – Preclinical etoposide oral Sensitive : D
PLAC8 overexpression	Germ Cell Tumors	PLAC8 overexpression	Germ Cell Tumors	etoposide oral Resistant: D – Preclinical etoposide oral Resistant : D	etoposide oral Resistant: D – Preclinical etoposide oral Resistant : D
CSMD3 mutation	Small Cell Lung Cancer	CSMD3 mutation	Small Cell Lung Cancer	etoposide oral Resistant: D – Preclinical etoposide oral Resistant : D	etoposide oral Resistant: D – Preclinical etoposide oral Resistant : D

etoposide oral

Associations
(33)

Associations
(33)

etoposide oral

Associations(33)

Associations(33)

Associations
(33)

Associations
(33)